Search Results For ''

  • Osprey secures GE Healthcare for global distribution of kidney imaging tech

    Medtech company Osprey Medical (ASX: OSP) has significantly increased its global distribution network having secured distribution of their kidney imaging portfolio by partnering with global giant GE Healthcare.  Under the 4-year agreement, GE will commercialise Osprey’s DyeVert portfolio which reduces the amount of contrast that reaches the kidney for imaging, and will assist medical professionals

    Read More
    Public
  • Lowest inflation read in Australia’s 72-year CPI history

    The Consumer Price Index (CPI) fell 1.9% in the June 2020 quarter according to the Australian Bureau of Statistics (ABS), with an annual deflation rate of 0.3%. Since 1949, this was only the third time annual inflation has been negative. The previous times were in 1962 and 1997-98. The June quarter fall was mainly the

    Read More
    Public
  • Boom or bust: retailing’s two-speed economy

    Shoppers engaging in retail therapy despite the spectre of even more serious job losses and mounting evidence the virus is far from vanquished. According to the Australian Bureau of Statistics, retail sales rose 2.4 per cent for the month of June, to $29.7 billion. This was an 8 per cent rise on the previous June

    Read More
    Public
  • SUDA gains regulatory approval for sale of insomnia treatment spray

    Australians suffering from insomnia could soon have relief from the disorder with SUDA Pharmaceuticals (ASX: SUD) gaining approval from the Therapeutics Goods Administration (TGA) for the sale of their ZolpiMist spray as a treatment for short-term insomnia.  The regulatory approval enables ZolpiMist to be sold in Australia and will assist their strategic partners in other

    Read More
    Public
  • Silver ratio returns to key level

    It can’t be this easy, can it? There is a large community of traders who focus purely on trading precious metals, with the weapons of choice being gold and silver. These precious metals are named as such because they are rare, beautiful, and have been desired by humans for the entirety of recorded history. In

    Read More
    Public
  • Cellmid secures US distribution to 40,000 salons for anti-aging hair care

    Australian health and biotech company Cellmid (ASX: CDY) is set to capitalise on rising health product retail sales in the United States having secured an exclusive distribution partnership with Tru Beauty Concepts and their network of 40,000 hair salons.  The 5-year distribution deal will provide Cellmid with access to Tru Beauty salons across 11 US

    Read More
    Public